Oxford trial could open up sight-saving drug to more NHS patients
Summary
A UK study shows that the drug adalimumab could protect the sight of a wider group of people with uveitis than previously believed.
Description from Oxfordmail.
Who is covering this
-
Oxford trial could open up sight-saving drug to more NHS patients
A UK study shows that the drug adalimumab could protect the sight of a wider group of people with uveitis than previously believed.
Comments
Comments need JavaScript.